Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT.
about
Determination of key structure-activity relationships in siRNA delivery with a mixed micelle system.Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapy.Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study.The pathogenesis of mixed-lineage leukemia.Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding.Pathogenetic, Clinical, and Prognostic Features of Adult t(4;11)(q21;q23)/MLL-AF4 Positive B-Cell Acute Lymphoblastic Leukemia.Pontin is a critical regulator for AML1-ETO-induced leukemia.The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20/RNF40/WAC-H2B ubiquitination axis.The AAA+ ATPase RUVBL2 is a critical mediator of MLL-AF9 oncogenesis.Silencing of ETV6/RUNX1 abrogates PI3K/AKT/mTOR signaling and impairs reconstitution of leukemia in xenografts.Pushing the limits: defeating leukemia stem cells by depleting telomerase.Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populations.Immortalization of human AE pre-leukemia cells by hTERT allows leukemic transformation.Biological and clinical implications of telomere dysfunction in myeloid malignancies.Combinatorial molecular marker assays of WT1, survivin, and TERT at initial diagnosis of adult acute myeloid leukemia.
P2860
Q35021068-A8031142-7986-4A53-972C-2BA5B75CDD5FQ35049985-470E9692-39D9-4B0A-9727-F0F557663E63Q35802220-9903D016-829E-44CD-991D-C28C7E7F4F80Q36052947-25E62A42-8DC7-4E5C-B5BB-D1AC6FF594FCQ36166902-5FDAE3A0-36BC-46BF-B45B-5DA9B9FA8DFEQ37970679-EF265EB9-9007-49A3-9140-C60273BBF386Q38310344-64DECDDE-1C4C-41CB-9479-D5C3BA103487Q38687570-560E11D8-0CDB-4622-85E2-ABB021AA9A5BQ39195622-6910EFFE-E755-40A0-B8DF-87CFF22B4205Q39441263-F0AFEDDB-0B25-4EA3-8593-D76EF158051AQ39551272-8233E5DC-9574-4CA4-B842-46771378BAB6Q41813318-3EEFE864-D515-4025-9118-60AB8E0D2168Q42242758-7A5A932B-64CA-4CFF-BBB5-504552D39162Q46980175-A6E311F0-62B6-4D72-9CF4-BE8C5B2834FDQ50858158-09D16D99-9197-406A-AE88-641389F62987
P2860
Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Leukemic fusion genes MLL/AF4 ...... f the telomerase subunit TERT.
@en
Leukemic fusion genes MLL/AF4 ...... f the telomerase subunit TERT.
@nl
type
label
Leukemic fusion genes MLL/AF4 ...... f the telomerase subunit TERT.
@en
Leukemic fusion genes MLL/AF4 ...... f the telomerase subunit TERT.
@nl
prefLabel
Leukemic fusion genes MLL/AF4 ...... f the telomerase subunit TERT.
@en
Leukemic fusion genes MLL/AF4 ...... f the telomerase subunit TERT.
@nl
P2093
P2860
P356
P1433
P1476
Leukemic fusion genes MLL/AF4 ...... f the telomerase subunit TERT.
@en
P2093
N Martinez Soria
P Garrido Castro
T H Brümmendorf
P2860
P2888
P304
P356
10.1038/LEU.2010.155
P577
2010-08-05T00:00:00Z